GlycoSyn’s GMP facilities can manufacture APIs by chemical synthesis at any scale for use in pre-clinical and clinical trials.
We cater to a wide range of clients from large pharmaceutical companies to small biotech startups.
GlycoSyn has conventional R&D and QC laboratories. We also have three GMP manufacturing areas including a multi-product 6,000ft2 (560m2) GMP compliant, intrinsically safe manufacturing facility, and a dedicated GMP compliant peptide synthesis facility.
Our concentrated expertise and nimble business model mean we are especially good at producing compounds that intrinsically require small-scale manufacture, such as potent vaccine adjuvants, orphan drug APIs or specialty commercial manufacture of key GMP ingredients.
60L glass reactor (-75 to +130 degrees)
250L glass-lined reactors & 1000L SS reactors
Freeze-drying and ultrafiltration
50L Hastelloy hydrogenerator (60 bar)
Hastelloy vacuum filter-dryer (area 0.2 sq.m; -20° to + 140°C; full vacuum to +3bar)
HEL reaction calorimeter & differential scanning calorimeter